JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

Summary of Three Toxicity Study of Repeated Intravenous Infusion of Exatecan Derivative-ADCs to Cynomolgus Monkey

Summary of Three Toxicity Study of Repeated Intravenous Infusion of Exatecan Derivative-ADCs to Cynomolgus Monkey

2026.07.28

Consideration of Implementation for Postmarketing Carcinogenicity Studies Based on a Retrospective Analysis of Approved New Drugs by US FDA in the Past Ten Years

Consideration of Implementation for Postmarketing Carcinogenicity Studies Based on a Retrospective Analysis of Approved New Drugs by US FDA in the Past Ten Years

2026.07.28

The Importance of Using Pathogen-Free NHP in Preclinical Studies-trifold brochure

The Importance of Using Pathogen-Free NHP in Preclinical Studies-trifold brochure

2026.07.28

JOINN PQRT Flyer

JOINN PQRT Flyer

2026.07.28

JOINN Non-Clinical trifold - Disease models

JOINN Non-Clinical trifold - Disease models

2026.07.28

JOINN Non-Clinical Flyer- Medical Device Platform

JOINN Non-Clinical Flyer- Medical Device Platform

2026.07.28

JOINN Non-Clinical Flyer - Developmental and Reproductive Toxicology

JOINN Non-Clinical Flyer - Developmental and Reproductive Toxicology

2026.07.28

JOINN Non-Clinical Flyer - Carcinogenicity

JOINN Non-Clinical Flyer - Carcinogenicity

2026.07.28

JOINN Non-Clinical - Medical Device Platform

JOINN Non-Clinical - Medical Device Platform

2026.07.28

JOINN Laboratories Brochure

JOINN Laboratories Brochure

2026.07.28

Welcome to download

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top